Department of Surgery, Division of Pediatric Surgery, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, OH 43205, United States.
Division of Pediatric Surgery, Department of Surgery, Zucker School of Medicine at Hofstra/Northwell, Cohen Children's Medical Center, New Hyde Park, NY, United States.
J Pediatr Surg. 2022 Apr;57(4):690-699. doi: 10.1016/j.jpedsurg.2021.04.001. Epub 2021 Apr 15.
Testicular germ cell tumors are uncommon tumors that are encountered by pediatric surgeons and urologists and require a knowledge of appropriate contemporary evaluation and surgical and medical management.
A review of the recommended diagnostic evaluation and current surgical and medical management of children and adolescents with testicular germ cell tumors based upon recently completed clinical trials was performed and summarized in this article.
In this summary of childhood and adolescent testicular germ cell tumors, we review the initial clinical evaluation, surgical and medical management, risk stratification, results from recent prospective cooperative group studies, and clinical outcomes. A summary of recently completed clinical trials by pediatric oncology cooperative groups is provided, and best surgical practices are discussed.
Testicular germ cell tumors in children are rare tumors. International collaborations, data-sharing, and enrollment of patients at all stages and risk classifications into active clinical trials will enhance our knowledge of these rare tumors and most importantly improve outcomes of patients with testicular germ cell tumors.
This is a review article of previously published and referenced level 1 and 2 studies, but also includes expert opinion level 5, represented by the American Pediatric Surgical Association Cancer Committee.
睾丸生殖细胞肿瘤是儿科外科医生和泌尿科医生常见的肿瘤,需要了解适当的当代评估以及手术和医疗管理。
基于最近完成的临床试验,对儿童和青少年睾丸生殖细胞肿瘤的推荐诊断评估以及当前的手术和医疗管理进行了回顾,并在本文中进行了总结。
在本文对儿童和青少年睾丸生殖细胞肿瘤的总结中,我们回顾了初始临床评估、手术和医疗管理、风险分层、最近的前瞻性协作组研究结果以及临床结果。提供了儿科肿瘤协作组最近完成的临床试验的总结,并讨论了最佳手术实践。
儿童睾丸生殖细胞肿瘤是罕见的肿瘤。国际合作、数据共享以及将所有阶段和风险分类的患者纳入积极的临床试验中,将提高我们对这些罕见肿瘤的认识,最重要的是改善睾丸生殖细胞肿瘤患者的预后。
这是一篇对以前发表的和引用的 1 级和 2 级研究进行综述的文章,但也包括美国儿外科协会癌症委员会代表的 5 级专家意见。